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Abstract 
Concanavalin A (Con A) is known to agglutinate human erythrocytes if the cells are pre-treated with a proteinase or neuraminidase. 
We report that untreated cells can also be made to agglutinate with the lectin if the lectin-bound cells are treated with anti-Con A 
antibodies, or if a neutral polymer such as serum albumin, polyvinylpyrrolidone or Ficoll is added. Thus, Con A falls in the category of 
‘incomplete’ lectins. The polymer induces Con A-agglutinability without altering the receptor number, or deformability of the cells. If the 
polymer is sequestered within erythrocyte ghosts, Con A is unable to agglutinate them; but the presence of the polymer only on the outer 
surface (as in intact cells) or on both the surfaces permits agglutinability. Thus, the site of the polymer effect resides on the outer surface 
of the membrane. The polymer, however, is unable to induce agglutinability in erythrocyte vesicles, whose membrane lacks skeletal 
proteins. The result suggests a positive role for the membrane skeleton in the process of agglutination brought about by the polymer, as is 
true also for the agglutination of proteinase-treated cells. In order to obtain detailed information on the proteins participating in 
agglutination, monospecific antibodies to spectrins, band 4.1 protein, ankyrin and the cytoplasmic domain of band 3 protein were 
internalized in erythrocytes. It is found that anti-spectrin and anti-band 3 cytoplasmic domain, but not their Fab’s, inhibit the Con 
A-mediated agglutinability partially, and anti-4.1 antibodies, as well as the Fab’s, inhibit the agglutinability substantially. Anti-ankyrin, 
however, was without any effect. The results confirm a positive role for the membrane skeleton in the Con A-mediated agglutination of 
normal erythrocytes in the presence of a neutral polymer, or in proteinase treated cells. We also provide evidence for requirement of 
Mg-ATP in the agglutination process. 
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1. Introduction 
Antibodies and plant lectins are called ‘complete’ or 
‘incomplete’ depending on whether they can directly ag- 
glutinate washed human erythrocytes or not [1,2]. The 
incomplete antibodies/lectins bind to erythrocytes, but fail 
to agglutinate them unless pre-treated with a proteinase or 
further treated with anti-lectin antibodies or a neutral 
polymer. Concanavalin A, perhaps the best studied and the 
most widely used lectin, binds to erythrocytes but requires 
Abbreviations: BSA, bovine semm albumin; Con A, concanavalin A; 
methyl-a-man, methyl-cY+mannopyranoside; PVP, polyvinylpyrroii- 
done; RCA, Ricinus communis agglutinin; SDS-PAGE, SDS-polyacryl- 
amide gel electrophoresis; TLCK, Na-p-tosyl-L-lysine chloromethyl ke- 
tone; TPCK, N-tosyl+phenylalanine chloromethyl ketone; WGA, wheat 
germ agglutinin. 
* Corresponding author. Fax: + 91 22 4146089. 
prior proteolysis of erythrocytes to agglutinate them. We 
show here that the untreated cells can also be agglutinated 
by Con A on the addition of anti-Con A antibodies, or in 
the presence of BSA, Ficoll or PVP. This places Con A in 
the category of incomplete lectins. 
In our earlier work we found that the pre-treatment of 
red cells with a proteinase causes the removal of surface 
charge in the form of glycophorin-associated sialic acid 
[3]. The agglutinability was found to rise in proportion to 
the removal sialic acid in peptide-bound form. Neur- 
aminidase-treatment also had a similar effect on the in- 
crease in agglutinability. Also, contrary to earlier belief, 
the membrane skeleton was found to be necessary for 
agglutination to occur [4]. We now provide confirmation of 
the role of the membrane skeleton in the process of 
agglutination by showing that sequestration of antibodies 
to skeletal proteins inhibits the ability of Con A to aggluti- 
nate the cells. 
000%2736/95/$09.50 0 1995 Elsevier Science B.V. All rights reserved 
SSDI 0005-2736(94)00282-7 
K.N. Pestonjamasp, N.G. Mehta / Biochimica et Biophysics Acta 1235 (1995) IO-20 11 
How does the neutral polymer bring about agglutinabil- 
ity in the cells in the presence of intact glycophorin? And, 
does the polymer-induced agglutinability also depend on 
the membrane skeleton? Gur results show that a factor on 
the outer cell surface plays an important role, and the 
membrane skeletal proteins also participate in the 
polymer-aided agglutination. The results, additionally, 
show that physiological concentrations of Mg-ATP are 
necessary for complete agglutination to occur. 
2. Materials and methods 
2.1. Materials 
The fine chemicals we.re purchased from Sigma, St. 
Louis, MO, USA, except the following: Con A, Sepharose 
4B, protein A-Sepharose, DEAE-Sephadex, Sephadex G-75 
and Ficoll, which were products of Pharmacia-LKB, Upp- 
sala, Sweden. Nitrocellulose membrane was purchased 
from Radiochemical Centre, Amersham, Bucks., UK. Fre- 
und’s adjuvant was obtalined from Difco Laboratories, 
Detroit, MI, USA. The laboratory reagents were obtained 
from local sources. Normal rabbit serum was obtained 
from an unimmunized animal from our Institute animal 
house. 
Several grades of (human and bovine) serum albumins 
were tried. Only those that did not form visible precipitate 
with Con A, and lead to the formation of rouleaux with an 
erythrocyte suspension of 10% hematocrit were used. These 
were either fatty acid-free, or were made so by the proce- 
dure of Chen [5]. 
2.2. Methods 
The collection of blood., washing of erythrocytes, deter- 
mination of lectin-mediate:d agglutination of red cells [3] 
and vesicles [4], determutation of deformability [6], and 
iodination of Con A, and its binding to red cells [4] have 
been described earlier as indicated. Ghosts were prepared 
according to Bennett [7], or Hanahan and Ekholm [8] and 
resealed. The large membrane skeleton-free vesicles were 
obtained as described by Leonard and Ohki [9], and the 
small vesicles according to Lutz et al. [lo]. SDS-polyacryl- 
amide gel electrophoresis was performed according to 
Laemmli [ 111. Protein was estimated according to Peterson 
[12] using BSA as the standard. 
2.3. Pronase / trypsin treatment of erythrocytes 
Five times washed erylhrocytes were incubated with 2 
vol. of 50 pg/ml Pronase or 200 pg/ml TPCK-trypsin in 
0.01 M Tris-HCl/O.lS M NaCl (pH 7.4) (buffer 1) at 
37” C for 1 h. The cells were washed four times in TBS in 
the cold. The washing was adequate to remove the pro- 
teinases, as the ghosts prepared from these cells had intact 
skeletal proteins; and also, the addition of TLCK to the 
cells after trypsin treatment and before washing, did not 
alter any membrane proteins, or affect the subsequent 
results of agglutinability. 
2.4. Preparation of monospecific antibodies 
The collection of human blood, washing of red cells 
and the preparation of ghosts were done essentially as 
described by Bennett [7]. After washing the ghosts in 
buffer 1 to remove band 6 protein [13], spectrin was 
extracted by incubation in 10~ ionic strength medium and 
purified by gel filtration chromatography [7]. Ankyrin was 
extracted from inside-out vesicles by incubation in 1 M 
KCl. The supernatant was dialyzed and passed through 
DEAE-Sepharose according to Tyler et al. [14]. The vesic- 
ular pellet was then incubated in 10 vol. of 3 mM p-chlo- 
romercuriphenylsulfonic acid in 5 mM phosphate buffer, 
pH 8.5, for 30 min at 37” C to remove band 4.2 [15]. The 
cytoplasmic domain of band 3 was cleaved by a-chymo- 
trypsin at 0” C and purified on DEAE-Sepharose [7]. Pro- 
tein 4.1 was purified from Triton shells of erythrocytes by 
the method of Ohanian and Gratzer [16]. The purity of the 
isolated proteins was checked by SDS-PAGE [ll]. The 
purified proteins were coupled to CNBr-activated 
Sepharose [ 171. 
The antiserum was obtained by injecting a rabbit subcu- 
taneously at several sites with 2 mg protein-equivalent of 
ghosts emulsified in Freund’s complete adjuvant. After 10 
days a booster of 1 mg ghost protein in the incomplete 
adjuvant was given, and blood was collected after 10 more 
days. The rabbit was intermittently boosted, and bled 
similarly. In order to increase the titer of anti-ankyrin and 
anti-4.1 protein, the same rabbit was later injected with the 
proteins of 1 M KCl-extract of inside-out vesicles [14]. 
The antisera were stored at -20” C after addition of 
0.02% azide. Anti-4.1 protein was also obtained by inject- 
ing another rabbit with 100 pg of the purified protein in 
complete adjuvant, followed 2 weeks later with 80 pg 
protein in the incomplete adjuvant. 
The monospecific antibodies were prepared by passing 
the antiserum against whole ghosts serially through 10 ml 
columns of spectrin-Sepharose (2 mg protein/ml), 
ankyrin-Sepharose (0.4 mg/ml), protein 4.1-Sepharose (0.1 
mg protein/ml), and Sepharose coupled to the cytoplasmic 
domain of band 3 (0.6 mg/ml). The columns were sepa- 
rated and washed extensively with 0.01 M Tris-HCl/O.S 
M NaCl (pH 7.4). The monospecific antibodies were eluted 
with 4 M MgCl, and dialyzed against distilled water, the 
pH of which was adjusted to 7.4 with ammonium bicar- 
bonate. After measuring the protein concentration (AzgOnm 
= 13.5 [18]), aliquots were lyophilized and stored at 
- 20” c. 
Antibodies to protein 4.1 were also obtained by absorb- 
ing the anti-4.1 antibodies to 80-100 kg of 4.1 protein 
bound to nitrocellulose strips. The latter were prepared by 
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electrophoretic transfer of purified 4.1 protein from 8% 
SDS-polyacrylamide gels run according to Laemmli [ll], 
and carefully cutting out the 4.la and b region after 
staining with Ponceau S. Purified spectrin was also elec- 
trophoresed and blotted on nitrocellulose. The nitrocellu- 
lose was cut to remove all polypeptides smaller than 
spectrin. This was used to pick up anti-spectrin antibodies. 
The antibody-absorbed strips were washed extensively with 
the high salt buffer, and the antibodies were extracted and 
processed similar to the column-purified antibodies. 
The Fab fragments were prepared by papainization of 
the IgG fraction of the antiserum obtained by ammonium 
sulfate precipitation at 40% saturation [19]. The monospe- 
cific Fab fragments were isolated in the same manner as 
the intact antibodies. The residual intact antibodies were 
removed by absorption on protein A-Sepharose. 
2.5. Specificity of the antibodies/ Fab fragments 
The erythrocyte membrane proteins were separated in 
several lanes on 5-E% polyacrylamide gel according to 
Laemmli [ll], and were blotted on to nitrocellulose [20]. 
The lanes were cut out, and one of them was stained with 
Ponceau S to visualize the separated proteins. After 
overnight blocking in 3% BSA in buffer 1, a nitrocellulose 
strip bearing the erythrocyte proteins was incubated in 0.5 
,ug/ml monospecific antibody in buffer 1 containing 0.3% 
BSA, 0.05% (v/v) NP-40 and 0.02% azide for 2 h. After 
five washes in buffer 1 it was incubated for 2 h with 
(1:lOOO dil) goat antiserum prepared against rabbit IgG. 
The strip was washed, and further incubated with peroxi- 
dase-(rabbit) antiperoxidase conjugate (1:3000 dilution) for 
1 h. After three washes, it was finally incubated with 0.5 
mg/ml 4-chloronaphthol and 0.015% H,O, for develop- 
ment of color. 
2.6. Entrapment of antibodies in erythrocytes and aggluti- 
nation with Con A 
1 vol. of normal or Pronase/trypsin-treated erythro- 
cytes was added to 4 vol. of a chilled solution of the 
monospecific antibody or its Fab fragment in 2 mM Mg- 
ATP/S mM Tris-HCl (pH 7.4). The cells were dispersed 
by tapping the tubes gently and were kept on ice for 10 
min for the completion of lysis. The control cells were 
lysed in the same solution devoid of any antibody. The 
suspension was made isoosmotic by the addition of an 
appropriate volume of 3 M KCl. The cells were incubated 
for 1 h at 37” C to reseal and to allow the antibodies to 
bind. They were then washed thrice in buffer 1 in the cold. 
The Con A-mediated agglutination of control and anti- 
body-entrapped cells was carried out as described earlier 
[31. 
The more agglutinable Pronase-treated cells were used 
to study the effects of all, except the anti-spectrin, antibod- 
ies. Preliminary experiments indicated slight stimulation of 
agglutination at low concentrations of the anti-spectrin 
antibody. For this reason, the slightly less agglutinable 
trypsinized erythrocytes were employed. 
In order to rule out the possibility that the differences in 
agglutination were due to any contaminating antibodies for 
extracellular determinants, intact trypsinized erythrocytes 
were treated with each of the monospecific antibodies in 
buffer 1 for 60 min. After washing, the Con A-agglutina- 
bility of the cells was determined. 
Fig. 1. Con A-mediated agglutination of human erythrocytes in the presence of anti-Con A antibodies. Washed human erythrocytes were suspended at 10% 
hematocrit in buffer 1, and Con A was added at the final concentration of 2.50 pg/ml. After incubation at 37” C for 1 h, the cells were centrifuged at 
400 X g for 5 min. The supernatant was discarded, and the cells were washed thrice. The cells were resuspended at 10% hematocrit, and the anti-Con A 
antibody was added in l:l, 1:4, 1:16 and 1:64 dilutions of the solution obtained from the supplier. To the second set, normal rabbit serum was added in 
similar dilutions. The agglutination was examined after 1 h at 37’ C. (A) 1:4 dilution of the anti-Con A antiserum; (B) undiluted non-immune serum. The 
bar in B corresponds to 10 pm. 
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2.7. Statistical analysis 
The agglutination differences between normal and anti- 
body/Fab-entrapped erythrocytes were statistically evalu- 
ated by paired t-test. The significant differences (P < 0.05) 
are denoted by asterisks in the figures. 
3. Results 
3.1. Agglutination of Con A.-bound erythrocytes by anti-Con 
A antibodies 
Anti-Con A antibodies added in dilutions of l:l, 1:4, 
1:16, 1:64 and 1:256 of the antiserum to Con A (250 
pg/ml)-bound erythrocytes, produced strong agglutination 
of the cells (Fig. 1A). Large clumps were seen at all 
dilutions with maximum clumping evident at 1:4 dilution. 
The clumps were resistant to vigorous vortexing, but inclu- 
sion of 0.05 M methyl-o-man abolished the agglutination 
(obviously by dissociating; the cell-bound Con A). The 
addition of normal rabbit serum in place of the anti-Con A 
antiserum did not produce agglutination (Fig. 1B). 
3.2. Con A-mediated agglutination of normal erythrocytes 
in the presence of albumin, Ficoll or PVP 
The addition of serum a.lbumin, Ficoll or PVP to the red 
cells treated with 250 pg./ml Con A produced shear-re- 
sistant clumps, In all cases, the presence of 0.05 M methyl- 
a-man did not permit agglutination. With bovine (or hu- 
man) serum albumin, maximum agglutination was ob- 
tained at 100 mg/ml (Fig. 2A). With Ficoll, agglutination 
was maximum at 50 mg,/ml (the highest concentration 
used) (Fig. 2B); while it nearly peaked at 50 mg/ml PVP 
(Fig. 2C). 
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Fig. 2. Agglutination of untreated human erythrocytes by Con A in the 
presence of neutral polymers. Washed human erythrocytes were incu- 
bated with 250 pg/ml Con A (II) for 1 h at 37” C. Serum albumin (A), 
PVP (B) or Ficoll (C) was addesd at various concentrations and further 
incubated for 1 h. The tubes were tapped firmly 15 times to break loose 
clumps, and the agglutination was quantitated microscopically. Each 
point indicates the mean+ SE. of five experiments. In each series a 
control was included that contained 250 pg/ml Con A and 0.05 M 
methyl-a-man (0 ), and the indicated concentrations of the polymer. 
In the above experiments the cells were first treated 
with Con A, and the polymer was added subsequently. 
Even when the sequence of addition of Con A and the 
polymer was reversed, or if the two were added simultane- 
ously, the agglutination was not affected (not shown). 
3.3. Binding of Con A in presence of the polymer 
The binding of ‘251-labeled Con A (250 pg/ml, which 
saturates the binding sites) to erythrocytes was studied in 
the presence of albumin (100 mg/ml), Ficoll (50 mg/ml) 
and PVP (25 mg/ml). PVP was found to have no signifi- 
cant effect of Con A binding to red cells: the number of 
binding sites (means f S.D. X 105) was 1.90 f 0.29 per 
cell in buffer 1 and 2.02 k 0.18 in the presence of PVP 
(P > 0.2). On the other hand, albumin was found to 
enhance the binding by about 50%, and Ficoll decrease it 
by almost 75%. However, we consider the albumin and 
Ficoll effects to be suspect for the following reasons: 
albumin, although ‘essentially globulin-free’, does contain 
l-3% globulins, most of which should be glycoproteins. 
These could bind to ‘251-Con A, and the aggregates, 
although not visible to the naked eye, could sediment 
through dibutylphthalate along with the cells. This could 
explain the higher number of sites. Sucrose is known to 
bind to Con A [21], and Ficoll which is polysucrose, may 
possess some affinity for the lectin. It could thus compete 
for Con A, reducing its binding to cells. 
3.4. Effect of polymers on deformability of erythrocytes 
Ficoll and PVP, at the concentrations used, produced 
rouleaux when added to an erythrocyte suspension of 10% 
hematocrit used in the deformability studies. Hence the 
deformability study was carried out only with albumin. It 
was found that 100 mg/ml albumin brought about a slight, 
but statistically significant, decrease in the deformability of 
red cells. The deformability index of untreated cells was 
0.698 + 0.06 (means f S.D.; n = 3). In the presence of 
100 mg/ml albumin the index (after correcting for the 
filtration time of BSA solution), was 0.606 f 0.044 (n = 3; 
P < 0.05). 
To further assess the role of deformability in polymer- 
mediated Con A-agglutinability, the cells treated with 5 
mM diamide were used. Diamide is known to drastically 
reduce the deformability of erythrocytes [22]. The nearly 
non-deformable cells, however, agglutinated with Con A 
in the presence of albumin, PVP or Ficoll as well as the 
normal erythrocytes (not shown). Thus, the polymers do 
not appear to bring about agglutinability by affecting the 
deformability of the cells. 
3.5. The site of polymer effect 
Is the effect of the polymer on agglutinability restricted 
to the outer cell surface, or can it also occur from the 
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cytoplasmic side of the membrane? Or, can the agglutina- 
tion occur if the polymer is present on both the surfaces? 
In order to test this, ghosts (which agglutinate well with 
Con A in the presence of any one of the three polymers), 
were suspended in a solution of 25 mg/ml PVP in buffer 
1 in the cold. The ghosts were then sealed by incubation at 
37” C for 1 h. Con A was added directly to these ghosts, 
which were exposed to the polymer on both the sides of 
the membrane. Alternatively, after resealing, the ghosts 
were washed with buffer 1 to remove the extracellular 
PVP and Con A was added. In the latter case, PVP was 
present only on the internal membrane surface. After incu- 
bation, the ghosts were examined by dark field microscopy 
for agglutination. 
It was found that the ghosts exposed to PVP on both the 
surfaces were agglutinated with Con A (Fig. 3B,C), but 
those with PVP only on the inside were not (Fig. 3A). 
Thus, the polymer effect appears to be confined to the 
external surface of erythrocytes. The simultaneous pres- 
ence of the polymer on the inner surface, however, does 
not interfere with its action on the outer surface of the cell. 
This result also shows that the polymer-induced Con A-ag- 
glutinability of erythrocytes is not a consequence of os- 
motic pressure differences across the membrane. 
In order to check if the polymer is indeed internalized, 
white ghosts were exposed to 10, 20 and 40 mg/ml BSA, 
and sealed. After washing, the ghosts were subjected to 
SDS-PAGE. A dose-dependent increase in the albumin 
content of the ghosts was found. At 40 mg/ml albumin, 
about 10% of the total ghost protein was BSA (not shown). 
3.6. The role of the membrane skeleton 
The microscopically visible ‘large’ vesicles lack the 
cytoskeletal proteins, bands 1, 2 (spectrins), 2.1 (ankyrin), 
4.la and b, 4.9 and 5 (actin) (Fig. 4A). These vesicles 
were not agglutinated with Con A (Fig. 4B), even when 
albumin, Ficoll or PVP was added at concentrations that 
produce heavy clumping in whole cells (Fig. 2). The 
vesicles, however, bound Con A at the same density as 
whole cells: the number of Con A binding sites (means + 
S.D. X lo51 per cell-equivalent of phospholipids were 1.21 
f 0.34 for whole cells and 1.51 & 0.45 for vesicles (P > 
0.4). The vesicles yielded large clumps with RCA and 
WGA (Fig. 4C). 
The small vesicles obtained by in vitro aging of erythro- 
cytes [lo] produced identical results (not shown). 
3.7. Specificities of the purified antibodies / Fab fragments 
The purified spectrin used for spectrin-Sepharose prepa- 
ration did not show any contamination by SDS-PAGE 
(Fig. 5A, lane b). Th e anti-spectrin antibodies isolated 
using the affinity column showed strong staining of the 
two spectrin bands (Fig. 5B, lanes b and cl but also light 
staining of a few low molecular weight peptides in ghost 
proteins (Fig. 5B, lane b). The anti-spectrin antibodies 
purified using nitrocellulose strips impregnated with pure 
spectrin (obtained by electrophoresis and blotting of puri- 
fied spectrin) also gave a similar picture (not shown). 
Since the nitrocellulose strip did not contain any proteins 
smaller than spectrins, the lower molecular weight peptides 
on the Western blot (Fig. 5B, lane b) most probably 
represent small amounts of spectrin degradation products 
occurring naturally in the erythrocyte membrane. 
The purified ankyrin appeared to be virtually pure by 
SDS-PAGE (Fig. 5A, lane c), but showed a small amount 
of band 2.2 protein by immunostaining (Fig. 5B, lane e). 
The antibodies to ankyrin stained all the three erythrocyte 
isoforms, i.e., bands 2.1, 2.2 and 2.3 (Fig. 5B, lane d), 
which are immuno-crossreactive [23]. 
Fig. 3. The sidedness of PVP action on the Con A-mediated agglutination of erythrocytes. White ghosts were incubated with 25 mg/ml PVP or buffer 1 
alone and sealed by incubation at 37” C for 1 h. In the former, the ghost membrane is exposed to PVP on both its sides. An aliquot of this was washed 
thrice to obtained ghosts, which have PVP only on the inside. To a portion of the ghosts sealed without PVP, 25 mg/ml PVP was added. Con A was added 
at 250 pg/ml to all preparations. After incubation for 1 h, agglutination was assessed by dark field microscopy. (A) PVP only inside (or ghosts without 
PVP on either side); (B) PVP only on outside; and (C) PVP on both sides. The bar in A is equivalent to 10 /*m. 
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The purified 4.1 protein migrated in SDS-PAGE pre- 
dominantly as a doublet of 80 and 78 kDa; but minor 
amounts of other bands were also found to be present (Fig. 
5A, lane d). These were polypeptides of about 85, 73, 53 
and 42 kDa. The monospecific antibodies obtained using 
the affinity column (Fig. 5B, lane f) or the nitrocellulose- 
bound pure 4.1 protein also stained the same bands. These 
bands correspond to the isoforms/degradation products of 
the protein reported in the literature (e.g., [24]). 
The purified cytoplasmic domain of band 3 protein 
migrated as a doublet on SDS-PAGE in the 43 kDa region 
(Fig. 5A, lane e>. Th e purified antibodies stained the intact 
band 3 protein, besides the bands of M, 60 000 and 42 000 
in ghosts (Fig. 5B, lane h). Band 3-related polypeptides of 
M, about 64000, 60000, 42 000 and 18 000-26000 have 
been identified in erythrocyte ghosts prepared in the pres- 
ence of proteinase inhibitors [25]. 
The presence of antibodies to other inappropriate pro- 
teins in each of the purified antibody preparation is ruled 
out from Fig. 5A (lanes b, d, f and h). Also, none of the 
antibodies reacted with inappropriate purified proteins 
when checked by immunoblotting (data not shown). When 
intact proteinase-treated erythrocytes were treated with 
each of the four monospecific antibodies and washed, none 
of the antibodies caused any change in the Con A-ag- 
glutinability of the cells. Thus, the observed effects of the 
antibodies were not due to any contaminating activity 
towards extracellular determinants. 
In order to rule out the possibility that residual pro- 
teinase activity rather than the antibodies was responsible 
Aabcde 
for the observed effect on agglutinability, the trypsinized 
erythrocytes, prior to antibody internalization, were treated 
with 20 pg/ml TLCK to inactivate the enzyme. When 
Con A-agglutinability was determined after washing, no 
difference was observed. Also, no changes were seen in 
the apparent intensity of any of the membrane skeletal (or 
other) proteins of the trypsin/Pronase-treated red cells on 
SDS-PAGE following antibody internalization and reseal- 
ing. Thus, the proteinase used for digestion of intact cells 
apparently does not persist after washing, nor does the 
process of lysis and resealing affect the membrane pro- 
teins. 
The purified antibodies were internalized in normal or 
Pronase/trypsin-treated erythrocytes. The Con A-mediated 
agglutination of the cells was examined (after addition of 
25 mg/ml PVP to normal cells). The results with both sets 
of the cells were nearly identical. Only the results with 
proteinase-treated cells are given below. 
3.8. Effect of anti-spectrin antibodies and the Fab frag- 
ments 
Anti-spectrin antibodies were internalized in trypsinized 
erythrocytes at 0, 0.2, 0.4, 0.8, 2.0, 4.0 and 6.0 mg/ml 
(Fig. 6). While 0.2 mg/ml produced a small stimulation, 
and 0.4 mg/ml had no apparent effect (not shown), the 
remaining four antibody concentrations produced inhibi- 
tion. The maximum effect, a little over 30%, was observed 
at 2.0 mg/ml. The extent of inhibition with the four 
B 
1L 
2- 
3/- 
4.laY_ 
4Sb- 
5- 
Fig. 5. (A) Purity of the isolated proteins and specificity of the purified antibodies. Electrophoresis of the isolated proteins was carried out on 8% 
polyacrylamide gels in the presence of SDS and mercaptoethanol. Lane a, ghost proteins (40 pg protein, Coomassie blue staining); lanes b-e, approx. 10 
pg protein per lane, silver staining. b, spectrin; c, ankyrin; d, band 4.1 protein; e, cytoplasmic domain of band 3 protein. (A composite picture of 
electrophoretic patterns obtained at different times.) (B) Specificities of the antibodies using erythrocyte ghosts and purified proteins (a composite picture). 
Lane a, Coomassie blue stained pattern of ghost proteins (same as Fig. la, lane a), lanes b-i, immunoblots. 30 pg ghost protein (lanes b, d, f and h), 4 pg 
spectrin (lane c), 5 pg ankyrin (lane e), 5 pg 4.1 protein (lane g) and 10 pg cytoplasmic domain of band 3 protein (lane i) were electrophoresed and 
transblotted. The blots were blocked and incubated with the corresponding monospecific antibodies (0.2 kg/ml) and visualized as described under 
Materials and methods. Lanes b and c developed with anti-spectrin antibodies; d and e with anti-ankyrin; f and g, with anti-4.1 protein; and h and i with 
anti-cytoplasmic domain of band 3. The polypeptides are numbered on the left according to [lo], and molecular weights are indicated on the right hand 
side. 
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Fig. 6. Effect of internalized anti-spectrin antibodies and their Fab 
fragments on the Con A-mediated agglutination of erythrocytes. 
Trypsinized erythrocytes were lysed in 4 volumes of chilled 0.005 M 
Tris-HCl (pH 7.41, containing the antibody or its Fab fragment and 2 mM 
Mg-ATP. After 10 min on ice an aliquot of 3 M KC1 was added to make 
the solution isoosmotic. Resealing of the cells was carried out by 
incubation at 37” C for 1 h. Subsequently, the cells were washed thrice 
with buffer 1 in the cold. Agglutination was carried out with various 
concentrations of Con A. Antibody concentrations used were 0 (a); 0.2 
(~1; 0.8 (W); 2.0 (A ); 4.0 (0) and 6.0 (+) mg/ml. 2.2 mg anti-spec- 
trin were pre-incubated with 2.0 mg purified spectrin and internalized 
(*). The results plotted are me.ans+S.E. of 4-7 experiments. In some 
cases the S.E. bars are not shown to avoid confusion. The inset shows the 
results obtained with the Fab fragment of the anti-spectrin antibodies. The 
same symbols are used as in the case of intact antibodies. Results are 
average of four experiments. 
antibody concentrations varied within 10% of each other; 
however, the standard errors of their mean effects varied 
considerably more. Incubation of 2 mg/ml anti-spectrin 
with 2 mg/ml purified spectrin before internalization com- 
pletely neutralized the agglutination-inhibiting ability of 
the antibody. The Fab fragments of anti-spectrin antibodies 
failed to produce any effect on agglutination up to a 
concentration of 4.0 mg/lml (Fig. 6, inset). 
Identical results were obtained with the antibodies ob- 
tained using the affinity column or the nitrocellulose strip 
bearing purified spectrin. 
3.9. Effect of anti-4.1 protein antibodies / Fab fragments 
The anti-4.1 protein antibodies inhibited Con A-media- 
ted agglutinability of Pronase-treated red cells in the range 
0.4 to 4.0 mg/ml in a concentration-dependent manner 
(Fig. 7A). At th e lg es concentration used, the inhibition h’ h t 
was nearly 75%. If the antibody was neutralized by pre- 
treatment with purified 4.1 protein, the inhibitory activity 
was totally abolished. The Fab fragments of the monospe- 
cific antibodies appeared to show even a greater effect, 
with the agglutination decreasing to about 10% at 2.0 
mg/ml (Fig. 7B). On a molar basis, however, the intact 
antibodies and Fab fragmlents had similar effects. 
The antibodies to 4.1 protein isolated using the affinity 
column or the 4.1 protein-impregnated nitrocellulose gave 
the same inhibition of agglutination. 
3.10. Effect of anti-ankyrin antibodies/Fab fragments 
Due to their low yield, the anti-ankyrin antibodies could 
be used only over the concentration range of 0.4 to 1.6 
mg/ml (Fig. 8). No significant stimulation or inhibition of 
agglutinability was observed at any of the concentrations. 
Since no progressive concentration-dependent change was 
observed, it is doubtful if increasing the concentration 
beyond 1.6 mg/ml would have produced a significant 
effect. Thus, it is concluded that anti-ankyrin antibodies 
have no effect on Con A-mediated agglutinability of ery- 
throcytes. The Fab fragments of the antibody were also 
ineffective up to the concentration of 1.6 mg/ml (Fig. 8, 
inset). 
d I I I I I 
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Fig. 7. Con A-agglutinability of erythrocytes following internalization of 
anti-4.1 protein antibodies/Fab fragments. (A) Anti-4.1 antibodies (a) at 
0 (P); 0.4 (v); 0.8 cm); 2.0 (A); and 4.0 (0) mg/ml. 4 mg/ml 
antibody was pre-incubated with 4 mg/ml purified 4.1-protein, and the 
complex was internalized (+ 1. (B) The Fab fragments at 0 (0 ); 0.4 ( T ); 
0.8 ( W) and 2.0 (A 1 mg/ml were internalized in Pronase-treated erythro- 
cytes, and the Con A agglutinability of the cells was determined after 
resealing and washing. Values are means* SE. of 3-7 experiments. 
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Fig. 8. Effect of internalized anti-ankyrin antibodies on the Con A-media- 
ted agglutination of erythrocytes. Anti-ankyrin antibodies were internal- 
ized in Pronase-treated erythrocytes at 0 (0); 0.4 (0); 0.8 cm); and 1.6 
(A) mg/ml. The Con A-agglutinability of the cells was determined after 
resealing and washing. The inset shows the results obtained with the Fab 
fragment of the anti-ankyrin antibodies. (The same symbols as those used 
for the intact antibodies.) Values are means of three or four experiments, 
the error bars are not shown. 
3.11. Effect of antibodies/Fab’s to the cytoplasmic do- 
main of band 3 protein 
Internalization of antibodies to the cytoplasmic domain 
of band 3 protein at 0, 0.8, 2.0 and 4.0 mg/ml in 
Pronase-treated cells produced a progressive concentra- 
tion-dependent inhibition of Con A-mediated agglutination 
loo1 
-Iti 
0 50 100 150 200 250 
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Fig. 9. Con A-agglutinability of erythrocytes following internalization of 
antibodies/Fab to the cytoplasmic domain of band 3 protein. Antibodies 
to the cytoplasmic domain of band 3 protein were internalized in 
Pronase-treated erythrocytes at 0 cm); 0.8 (m ); 2.0 (A) and 4.0 (0) 
mg/ml. 4mg/ml antibody and 2.0 mg/ml purified band 3 cytoplasmic 
domain were incubated before internalization (T 1. The Con A-agglutina- 
bility of the cells was determined after resealing and washing. Values are 
means&SE. of 4-7 experiments. Inset shows results obtained with the 
Fab fragments of these antibodies. (Symbols are the same as in the case 
of intact antibodies. Values are means f SE. of four experiments.) 
[CON Al ((Wml) 
Fig. 10. Effect of intracellular Mg-ATP on the Con A-agglutinability of 
erythrocytes. Pronase-treated cells were lysed in hypotonic medium lack- 
ing (A) or containing (m) 2 mM Mg-ATP or 2 mM Mg-ATP-analogue 
(0). After resealing their agglutinability by Con A was determined. The 
agglutinability of fresh unlysed Pronase-treated erythrocytes is also shown 
(a). Values are means+ SE. of five experiments. The difference be- 
tween the agglutinabilities of ghosts without ATP and with ATP internal- 
ized was statistically significant at all Con A concentrations. The differ- 
ence between the intact cells and the ATP internalized ghosts was not 
significant. The difference between the agglutination of ATP-internalized 
and the ATP-analogue-internalized cells was also statistically significant. 
(Fig. 9). At 4.0 mg/ml of the antibody, 50% inhibition of 
agglutination was observed (at 50 pg/ml Con A). Incuba- 
tion of 4 mg/ml of the antibody with equal amount of the 
purified band 3 cytoplasmic domain completely abrogated 
the effect of the antibody. The Fab fragments of the 
antibodies had no effect even at 4.0 mg/ml (Fig. 9, inset). 
3.12. Role of Mg-ATP 
When Pronase-treated erythrocytes were lysed in 4 vol. 
of buffer and the agglutination of the cells was assessed 
after resealing, a substantial decrease (varying between 
40-50% at different concentrations of Con A) was ob- 
served (Fig. 10). When the lysis was carried out in the 
presence of 2 mM Mg-ATP (the approximate intracellular 
concentration in red cells), the decrease in agglutination 
did not occur. If instead of Mg-ATP, Mg*+ and p,y- 
methylene adenosine triphosphate (a non-hydrolyzable 
analogue of ATP) were included at the same concentration, 
the decrease persisted. The decrease was again observed if 
Mg*+ or ATP alone was present. Thus, for normal Con 
A-mediated agglutination of erythrocytes, the presence of 
Mg-ATP is required. 
4. Discussion 
It has been known for a long time [26] that Con A is 
unable to agglutinate normal human erythrocytes, but pre- 
treatment of the cells with proteinase/neuraminidase makes 
them agglutinable with the lectin. The results reported here 
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that anti-Con A antibodies and neutral polymers elicit 
agglutinability in normal cells, place Con A in the category 
of ‘incomplete’ lectins [ll. 
The proteinase treatment does not bring about the ag- 
glutinability by altering the number of Con A binding sites 
[3] or the deformability of the cells [6]. The polymer-in- 
duced agglutinability also does not arise by altering these 
parameters. The increase in Con A-agglutinability follow- 
ing proteinase/neuraminidase treatment is correlated (r = 
0.88) with the removal of sialic acid, predominantly asso- 
ciated with glycophorin A. [3]. The latter is non-covalently 
complexed with band 3 in the membrane [27,28]. Since 
aggregation of lectin-receptor complexes is required for 
shear-resistant agglutination [29], the highly negatively 
charged glycophorin can interfere with the aggregation of 
Con A-band 3 complexes, thus preventing agglutination. 
The removal of charge leads to aggregation of band 3 
molecules following Con A binding [30,31]. How is the 
neutral polymer then able to bring about agglutinability in 
the presence of intact glycophorin? Pollack et al. [32] 
studying the polymer-induced agglutination of erythrocytes 
by anti-Rh antibody, showed that the polymer decreases 
the zeta potential on the membrane by increasing the 
dielectric constant of the medium. This would, in effect, 
amount to reduction in surface charge. Indeed, the site of 
the polymer effect is located on the external surface of the 
cell membrane (Fig. 3). (However, another report [33] 
failed to find any effect of neutral polymers on the zeta 
potential.) 
The vesicles lacking skeletal proteins in their membrane 
fail to agglutinate with Con A whether isolated from 
proteinase-treated [4] or normal erythrocytes (Fig. 4). Thus, 
despite a 50-fold increase in the lateral mobility of the Con 
A receptor [34], the removal of skeletal proteins leads to 
loss of agglutinability with Con A. The inhibition of 
agglutination by anti-spectrin and anti-4.1 protein reported 
here, confirms the participation of the membrane skeleton 
in the process of agglutination. This requirement, again, is 
common for the proteinase- and polymer-mediated aggluti- 
nations. 
Since only the intact anti-spectrin antibodies, and not 
the Fab’s, inhibit agglutination, the inhibitory activity is 
due to cross-linking of spectrin molecules. Also, the extent 
of inhibition is no more than 30%, and beyond 2 mg/ml 
antibody concentration (Pig. 6), there is no further effect. 
This suggests the involvement of a very small number of 
epitopes on the spectrin molecules, and that the epitopes 
are not uniformly accessible to the antibodies. The inhibi- 
tion by anti-4.1 antibodies is quite substantial, and concen- 
tration dependent (Fig. 7A). Since the Fab fragments of the 
antibodies are as effective (Fig. 7B), evidently a domain 
on the 4.1 protein partici;pates in the agglutination process. 
Anti-ankyrin antibodies/Fab’s have no effect on agglu- 
tination (Fig. 8), but antibodies to band 3 cytoplasmic 
domain are inhibitory (Fig. 9). How could the cytoplasmic 
domain of the Con A receptor influence agglutination? In 
view of the participation of the membrane skeleton, and 
the lack of involvement of ankyrin, we envisage a Con 
A-induced interaction between the cytoplasmic tail of band 
3 and the membrane skeleton. Such a linkage is supported 
by the fact that Con A binding prevents the extraction of 
the spectrin-actin complex from the membrane under hy- 
potonic conditions [31]. The reported effects of Con A on 
erythrocytes, such as stabilization of the shape [35], de- 
crease in deformability [6], and the resistance to fragmenta- 
tion on heating at 49” C [31] can also be consequences of 
such an interaction. Since 49” C is the denaturation temper- 
ature of spectrin [36], an alteration in physicochemical 
properties of spectrin is suggested as a result of Con A 
binding to the cell. This possibly indicates an interaction 
between the cytoplasmic domain of band 3 with spectrin, 
although interaction with other components is also possi- 
ble. For example, the cytoplasmic domain of band 3 
possesses a binding site for 4.1 protein [24,37]. 
The concentrations of the various antibodies required 
for inhibition of agglutination is apparently quite large: 0.4 
to 6.0 mg/ml, corresponding to about 2.5 . 10e6 to 4 . 
lop5 M. During hypotonic lysis, proteins of high molecu- 
lar weight (106) can get into the cell, but the pores in the 
membrane exist for only about 10 set [38]. Whether 
equilibration between extra- and intra-cellular materials 
occurs during this time is not clear. (The indicated anti- 
body concentrations would thus be only notional.) Further, 
since the antibodies used are polyclonal, the concentration 
of the antibody to each of the antigenic epitopes will be 
much smaller. Thus, although apparently large, the concen- 
tration of the epitope-specific antibody available within the 
cell may not be very large. The extent of antibody binding 
will be further determined by its affinity for the antigen. 
Shear-resistant agglutination of cells requires a ligand- 
induced pre-aggregation of receptor molecules [29]. The 
aggregation of not only band 3 molecules, but also of 
skeletal proteins is observed in agglutinated cells, as de- 
tected by chemical cross-linking [30,31]. The membrane 
skeleton is associated with contractile proteins 1391 that 
could help in the process of aggregation. (The slight 
stimulation of agglutination seen at 0.2 mg/ml anti-spec- 
trin (Fig. 6) may be due to a mild aggregation of spectrin 
produced at the low concentration of the antibody.) Some 
reports indicate that lectin-induced patches of receptor 
molecules coaggregate with spectrin/ankyrin in nucleated 
cells [40-421. Fodrin (non-erythrocyte spectrin) has been 
reported to stimulate actomyosin-associated Mg-ATPase 
[43]. It is conceivable that the physicochemically altered 
spectrin molecule in the Con A-bound cells (discussed 
above), could bring about the stimulation. The ensuing 
contraction of the skeletal structure could account for the 
aggregation of skeletal proteins, and together with them, of 
the band 3 molecules putatively attached to them. Also, 4.1 
protein, apart from being associated with spectrin and 
actin, and possessing a binding site for band 3 molecules 
[24,37], is reported to be complexed with myosin, and to 
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regulate the actin-mediated activation of myosin-ATPase 
[44]. Possibly the binding of anti-4.1 antibody/Fab to the 
4.1 protein molecule interferes with this activation, and the 
subsequent force generation. The substantial inhibitory 
effect of anti-4.1 antibody, and its Fab, is thus not surpris- 
ing. 
If contraction of the skeleton helps in aggregation of 
band 3-Con A complexes, and eventually in agglutination, 
the latter should be dependent on ATP. The preliminary 
evidence presented here on the requirement of physio- 
logical concentrations of Mg-ATP for full agglutination 
indicates such a dependence. Also, the phosphorylation of 
the tyrosine residue at position 418 in the amino acid 
sequence of the 4.1 molecule is reported to reduce the 
latter’s ability to promote spectrin-actin assembly, and to 
bind to band 3 protein [4.5]. ATP thus may influence the 
agglutinability in more than one way. 
The conditions bringing about agglutination of cells by 
incomplete lectins and antibodies are identical. It should 
therefore be surprising if the two groups of ligands did not 
produce agglutination by the same mechanism. The in- 
volvement of the membrane skeleton in the Con A-media- 
ted, but not RCA- or WGA-mediated [4], agglutination 
suggests that the membrane skeleton may be required for 
the agglutination by the incomplete (anti-Rh) but not the 
complete antibody. While the present results rule out any 
role for deformability in the polymer-induced agglutination 
by Con A, an earlier report has implicated a major role for 
deformability in anti-Rh-mediated agglutination [46]. A 
reassessment of this role may be worth while. Interest- 
ingly, recent results have shown that the Rh antigen is a 
component of a complex of several polypeptides, including 
glycophorin B [47]. The inhibitory role of the latter, simi- 
lar to that of glycophorin A in the Con A-mediated aggluti- 
nation, can easily be envisaged. 
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